Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemo-inducible gene therapy.

James J Mezhir1, Hank Schmidt, Bakhtiar Yamini

  • 1Department of Surgery, University of Chicago Hospitals, Chicago, Illinois 60637, USA.

Anti-Cancer Drugs
|October 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Household income and adverse childhood outcomes after prenatal myelomeningocele repair.

American journal of obstetrics & gynecology MFM·2026
Same author

Evolution of the MUC1 gene in eutherian mammals as an adaptation responsible for the increasing incidence of cancer in humans.

Biochimica et biophysica acta. Reviews on cancer·2026
Same author

The Infundibulum-Aneurysm Conundrum: A Longitudinal Single-Center Analysis.

AJNR. American journal of neuroradiology·2025
Same author

Systemic STING agonist therapy drives expression of interferon stimulated genes and downstream production of cytokines in dogs with solid tumors.

Journal for immunotherapy of cancer·2025
Same author

Craniofrontonasal dysplasia: A case report.

Pediatric discovery..·2025
Same author

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy.

JCI insight·2025
Same journal

Akt inhibitor-IV in estrogen receptor-positive breast cancer cells: cytotoxic, apoptotic, transcriptional, and in-silico comparison with tamoxifen.

Anti-cancer drugs·2026
Same journal

Prolonged multimodal disease control with trifluridine/tipiracil plus bevacizumab in KRAS-mutant metastatic rectal cancer: a case report.

Anti-cancer drugs·2026
Same journal

Growth differentiation factor-11 inhibits the progression of acute myeloid leukemia and increases chemosensitivity by inhibiting cathepsin S.

Anti-cancer drugs·2026
Same journal

Inavolisib and lenvatinib for PIK3CA-mutated refractory splenic angiosarcoma: a case report.

Anti-cancer drugs·2026
Same journal

Drug repurposing of liver cancer based on multimodal neural network and virtual screening.

Anti-cancer drugs·2026
Same journal

Discovery of an orally active and liver-targeted dual prodrug of 5-fluoro-2'-deoxyuridine-5'-monophosphate for the treatment of hepatocellular carcinoma.

Anti-cancer drugs·2026
See all related articles

Chemo-inducible cancer gene therapy uses viral vectors to activate cancer-killing genes with chemotherapy, enhancing tumor treatment and reducing side effects for solid tumors.

Area of Science:

  • Oncology
  • Gene Therapy
  • Cancer Research

Background:

  • Solid tumors present challenges for traditional chemotherapy due to toxicity and limited efficacy.
  • Gene therapy offers novel strategies to target cancer cells more specifically.
  • Chemo-inducible systems provide a mechanism for controlled transgene expression.

Purpose of the Study:

  • To explore the potential of chemo-inducible cancer gene therapy for solid tumors.
  • To investigate the enhancement of anti-tumor effects of chemotherapy.
  • To assess the minimization of treatment-related toxicity.

Main Methods:

  • Utilizing viral vectors to deliver cytotoxic transgenes.
  • Implementing transcriptional activation of transgenes by DNA-damaging agents (chemotherapy).

Related Experiment Videos

  • Evaluating the therapeutic efficacy and safety in preclinical models.

    • Main Results:

    • Demonstrated successful transcriptional activation of cytotoxic transgenes by chemotherapy.
    • Observed enhanced anti-tumor activity compared to chemotherapy alone.
    • Indicated a potential for reduced systemic toxicity.

    Conclusions:

    • Chemo-inducible gene therapy is a promising approach for solid tumor treatment.
    • This strategy can potentiate chemotherapy's anti-tumor effects.
    • Further development holds implications for localized and metastatic cancer treatment.